#67 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians should understand that THC impairs neural synchrony and information processing in ways that may increase psychosis risk, particularly in vulnerable patients with personal or family histories of psychotic disorders. This mechanistic evidence supports current clinical guidelines recommending against cannabis use in patients with psychosis or psychosis risk and informs risk stratification discussions with patients considering cannabis for other indications. Knowledge of these neurobiological effects enables clinicians to provide evidence-based counseling about the psychiatric harms of cannabis and to monitor patients who use cannabis despite these risks.
This study investigates the neurobiological mechanisms by which delta-9-tetrahydrocannabinol (THC) affects neural synchrony and information processing, with particular relevance to psychosis risk. Dysregulation of neural synchrony, particularly in gamma-band oscillations, has been implicated in psychotic disorders, and THC appears to disrupt these normal patterns of brain activity and communication between neural networks. These findings provide mechanistic insight into why acute THC use is associated with transient psychotic symptoms and why regular cannabis use, especially in genetically vulnerable individuals, carries elevated risk for psychotic disorders including schizophrenia. Understanding how THC disrupts fundamental neural processing offers a neurobiological framework for counseling patients with personal or family histories of psychosis about cannabis risks. Clinicians should consider this neurophysiological mechanism when discussing cannabis safety with patients and when evaluating new-onset psychotic symptoms in cannabis users, as THC-induced alterations in neural synchrony may explain the dose and frequency dependent relationship between cannabis exposure and psychotic outcomes.
“This is an interesting mechanistic study that helps us understand how THC might influence neural processing, but we’re looking at early-stage research that needs replication in larger human cohorts before we can draw firm clinical conclusions about psychosis risk in individual patients.”
🧠 While cannabis use and psychotic symptoms have long been associated epidemiologically, this research examining THC’s effects on neural synchrony provides mechanistic insight into how cannabinoids may disrupt information processing in ways that could precipitate or exacerbate psychosis. The challenge for clinicians is that individual vulnerability varies substantially based on genetics, developmental stage, baseline psychiatric risk, and dosing patterns, making it difficult to predict who will experience psychotic sequelae from use. Furthermore, many patients report using cannabis specifically for anxiety or sleep, perceiving benefit despite potential long-term neural risks, creating a tension between symptom relief and harm reduction. When counseling patients—particularly adolescents and those with personal or family history of psychosis—it remains important to discuss not only the association between cannabis and psychotic disorders but also the emerging mechanistic understanding that THC may disrupt neural communication patterns in ways relevant to psychotic symptomatology. Clin
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
